BOSTON, February 28, 2022 — Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Aravind Subramanian, Ph.D., as Head of […]

BOSTON, September 28, 2021— Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Lori Escobedo as Chief People Officer.

Dewpoint congratulates our scientific founder, Tony Hyman, for his election to the German Academy of Sciences Leopoldina. This prestigious award […]

BOSTON, June 16, 2021 — Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Michael Wagner, Ph.D., as Senior […]

BOSTON, April 21, 2021 — Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Isaac Klein, M.D., Ph.D., as Chief […]

A new article focused on fluorescence methods to characterize biomolecular condensates was published in Methods in Microbiology. The article, co-authored […]

BOSTON, March 9, 2021 – Volastra Therapeutics and Dewpoint Therapeutics today announced a research and development partnership to discover novel modulators of biomolecular condensates […]

BOSTON, February 16, 2021 – Dewpoint Therapeutics, the biomolecular condensates company, today announced that it has appointed Regina Barzilay, Ph.D., to its […]

Isaac Klein, M.D., Ph.D. How did the discovery of condensates transform our understanding of the cell? We thought the cell […]